john robert

What are the warnings for abiraterone?

Abiraterone (brand name Zytiga) is a medication used primarily to treat metastatic castration-resistant prostate cancer (mCRPC) and high-risk, localized prostate cancer when combined with prednisone. While it can be very effective, it also comes with some important warnings and precautions that patients should be aware of. Here are the main warnings associated with abiraterone: